Status:
COMPLETED
Toward High Fidelity Adaptive Radiotherapy in the Thorax
Lead Sponsor:
Henry Ford Health System
Conditions:
Carcinoma, Non-Small-Cell Lung
Eligibility:
All Genders
18+ years
Brief Summary
Daily adaptive radiotherapy with individualized planning margins for thoracic and pelvic cancer patients will increase the potential of reducing dose to OARs, thereby reducing treatment-related toxici...
Detailed Description
1. To individualize the planning margins used for treatment, we will assess the impact of the different uncertainties on patient-specific planning margins. We determine the dosimetric uncertainties fo...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Histologically confirmed non-small cell lung cancer patients
- Locally advanced
Exclusion
Key Trial Info
Start Date :
February 5 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 27 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04731571
Start Date
February 5 2021
End Date
February 27 2025
Last Update
June 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henry Ford Health
Detroit, Michigan, United States, 48202